Cinpanemab therapy does not prevent Parkinson’s disease progression
1. Cinpanemab did not show clinical efficacy in preventing early Parkinson’s disease (PD) progression compared to placebo. 2. There was ...
Tag: Parkinson Disease
2 Minute Medicine Rewind May 22nd, 2022
Effect of Physician Consultation on Satisfaction With Hearing Aid Use 1. In a trial of patients with hearing loss, a ...
Tremor and memory symptoms prior to diagnosis demonstrate the strongest associations with subsequent Parkinson disease
1. In a diverse population with universal access to health care, tremor and impaired memory symptoms prior to diagnosis had ...
Adjuvant treatment with catechol-O-methyltransferase inhibitors inferior to monoamine oxidase type B inhibitors or dopamine agonists in patients with Parkinson disease uncontrolled by levodopa therapy
1. No significant improvement in quality of life was observed between treatment with dopamine agonists compared to dopamine reuptake inhibitors ...
Physical activity is associated with a reduction in all-cause mortality in patients with newly diagnosed Parkinson Disease
1. Newly diagnosed Parkinson Disease patients who were active had an associated reduced all-cause mortality compared to those who were ...
Influenza is associated with an increased odds of Parkinson Disease diagnosis after 10 years
1. Inpatient or outpatient clinic diagnosed influenza infection was associated with an increased odds ratio of diagnosis with Parkinson Disease ...
Pimavanserin continuation lower psychosis relapse risk in patient with dementia-related psychosis
1. Pimavanserin was shown to lead to a lower risk of relapse of psychosis in patients who had an initial ...
Home health management of patients undergoing deep brain stimulation for Parkinson’s disease is safe and feasible
1. Among patients receiving deep brain stimulation for Parkinson’s disease, a home health management program was found to be safe, ...
Focused ultrasound subthalamotomy revealed improvement in Parkinson’s patients
1. In patients suffering from Parkinson’s disease displaying signs of motor dysfunction even after receiving treatment, this randomized control trial ...